From Name

From Email

To Name

To Email

Message

Statewide success of staged sacral neuromodulation for the treatment of urinary complaints in California

from FPMRS

Statewide success of staged sacral neuromodulation for the treatment of urinary complaints in California FPMRS Sacral neuromodulation (SNS) is approved by the Food and Drug Administration as a third-line treatment for refractory overactive bladder, idiopathic urinary retention and fecal incontinence. Prior to implantation of an implantable pulse generator, all patients undergo a trial phase to ensure symptom improvement. The published success rates of progression from the test phase to permanent implant vary widely (range, 24% to >90%). READ MORE

more